124 related articles for article (PubMed ID: 11085580)
1. Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta).
Wilson LA; Murphey-Corb M; Martin LN; Harrison RM; Ratterree MS; Bohm RP
J Med Primatol; 2000 Aug; 29(3-4):173-81. PubMed ID: 11085580
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu K; Ohkawa S; Woodson B; Bohm R; Blanchard J
J Immunol; 1999 Jan; 162(1):540-9. PubMed ID: 9886431
[TBL] [Abstract][Full Text] [Related]
3. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
4. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
Johnson RP; Glickman RL; Yang JQ; Kaur A; Dion JT; Mulligan MJ; Desrosiers RC
J Virol; 1997 Oct; 71(10):7711-8. PubMed ID: 9311855
[TBL] [Abstract][Full Text] [Related]
5. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
6. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
[TBL] [Abstract][Full Text] [Related]
7. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
8. Effects of intestinal survival surgery on systemic and mucosal immune responses in SIV-infected rhesus macaques.
Edghill-Smith YY; Aldrich K; Zhao J; Pinczewski J; Kalyanaraman VS; Johnson M; Heyliger A; Perrin RP; Woodward R; Robert-Guroff M
J Med Primatol; 2002 Dec; 31(6):313-22. PubMed ID: 12519209
[TBL] [Abstract][Full Text] [Related]
9. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
10. Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.
Kent SJ; Hu SL; Corey L; Morton WR; Greenberg PD
J Virol; 1996 Aug; 70(8):4941-7. PubMed ID: 8763998
[TBL] [Abstract][Full Text] [Related]
11. Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.
McKay PF; Schmitz JE; Barouch DH; Kuroda MJ; Lifton MA; Nickerson CE; Gorgone DA; Letvin NL
J Immunol; 2002 Jan; 168(1):332-7. PubMed ID: 11751978
[TBL] [Abstract][Full Text] [Related]
12. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
[TBL] [Abstract][Full Text] [Related]
13. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection.
Vingert BC; Le Grand R; Venet A
Microbes Infect; 2003 Jul; 5(9):757-67. PubMed ID: 12850201
[TBL] [Abstract][Full Text] [Related]
15. Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys.
Schmitz JE; Veazey RS; Kuroda MJ; Levy DB; Seth A; Mansfield KG; Nickerson CE; Lifton MA; Alvarez X; Lackner AA; Letvin NL
Blood; 2001 Dec; 98(13):3757-61. PubMed ID: 11739183
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
17. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.
Stahl-Hennig C; Eisenblatter M; Franz M; Stoiber H; Tenner-Racz K; Suh YS; Jasny E; Falkensammer B; Ugucchioni M; Georgsson G; Baroni C; Dierich MP; Lifson JD; Steinman RM; Uberla K; Racz P; Ignatius R
Front Biosci; 2007 Jan; 12():2107-23. PubMed ID: 17127448
[TBL] [Abstract][Full Text] [Related]
18. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
Fuller DH; Rajakumar PA; Wilson LA; Trichel AM; Fuller JT; Shipley T; Wu MS; Weis K; Rinaldo CR; Haynes JR; Murphey-Corb M
J Virol; 2002 Apr; 76(7):3309-17. PubMed ID: 11884556
[TBL] [Abstract][Full Text] [Related]
19. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques.
Lohman BL; Miller CJ; McChesney MB
J Immunol; 1995 Dec; 155(12):5855-60. PubMed ID: 7499875
[TBL] [Abstract][Full Text] [Related]
20. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination.
Baig J; Levy DB; McKay PF; Schmitz JE; Santra S; Subbramanian RA; Kuroda MJ; Lifton MA; Gorgone DA; Wyatt LS; Moss B; Huang Y; Chakrabarti BK; Xu L; Kong WP; Yang ZY; Mascola JR; Nabel GJ; Carville A; Lackner AA; Veazey RS; Letvin NL
J Virol; 2002 Nov; 76(22):11484-90. PubMed ID: 12388710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
